Accelerating Drug Discovery for Frontotemporal Degeneration supports researchers and clinicians developing small molecules and biologics to advance disease-modifying treatments for frontotemporal dementia.
ADDF Diagnostics Accelerator Funding for FTD Biomarker Development supports FTD researchers through a partnership with The Association for Frontotemporal Degeneration to advance biomarkers for diagnosis and treatment.
The Treat FTD Fund from the Alzheimer's Drug Discovery Foundation supports early-stage research and clinical trials to develop new therapies and biomarkers for frontotemporal degeneration.
The Treat FTD Fund supports early-stage clinical trials for innovative FTD treatments, prioritizing biomarker integration and novel trial designs, funded by The Association for Frontotemporal Degeneration.
Drug Development RFP supports researchers and clinicians developing drugs and devices through IND-enabling studies and early clinical trials to advance treatments for Alzheimer’s disease and related dementias.